Patient Pathways
Patient Pathways aim to improve the care and management of patients with a rare disease. They include the “red flags” that may lead to the suspicion of the disease, how to reach a definite diagnosis and the management and follow-up recommendations. They are a very important tool used in defining the best patient care and will be further validated and updated when needed.
The CADASIL Patient Pathway document, prepared by the VASCERN NEUROVASC Working Group, outlines a comprehensive patient management strategy for CADASIL. It details diagnostic, genetic testing, and follow-up protocols for asymptomatic and symptomatic individuals, including the role of geneticists, neurologists, and multidisciplinary care teams. The pathway emphasizes the importance of specialized centers for accurate diagnosis and management.